News
Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...
Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
We wanted to price it in India in a way which is comparable to the therapies that are available,' said Vikrant Shrotriya, ...
The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...
Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...
Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication: ...
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback